SEC Form 4 · accession 0001209191-17-036789
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Thomas
Director
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 30, 2017 | G | 12,500 | $0.00 | D | 294,902 | D |
Table II — derivative securities
No Table II lines on this filing.